Sequencing Throughout Leukemia Treatment Unveils Therapy-Induced Changes in Mutational Profile

The Oxford team found four distinct classes of mutations in CLL tumors: those that disappeared following treatment; those that remained present at low levels throughout the entire course of treatment; those that expanded; and those that emerged over time.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.